Literature DB >> 29892470

Left Ventricular Dysfunction in the Setting of Takotsubo Cardiomyopathy: A Review of Clinical Patterns and Practical Implications.

Kenan Yalta1, Mustafa Yilmaztepe1, Cafer Zorkun1.   

Abstract

Takotsubo cardiomyopathy (TTC) is primarily regarded as a form of acute and transient myocardial disease with a variety of characteristic wall-motion abnormalities. Importantly, a significant portion of TTC cases generally present with variable degrees of acute left ventricular (LV) dysfunction with or without clinical HF. On the other hand, LV dysfunction in the setting of TTC has been universally and exclusively considered as a synonym for systolic dysfunction, potentially overlooking other forms of myocardial pathologies, including transient diastolic dysfunction, in this setting. More interestingly, recent observations suggest that TTC, despite its macroscopic recovery, may not always manifest as a fully reversible phenomenon, suggesting persistence of microscopic changes at the cellular level to some degree. In clinical practice, these residual changes might largely account for the evolution of certain pathologies, including persistent diastolic dysfunction and subclinical LV dysfunction with variable symptomatology (particularly those arising during high levels of myocardial workload, including exercise, etc.) among TTC survivors. Within this context, the present review aims to highlight various clinical patterns and implications of LV dysfunction in the setting of TTC, and to provide basic information regarding morphological and mechanistic characteristics of wall-motion abnormalities in this setting.

Entities:  

Keywords:  Takotsubo cardiomyopathy; clinical heart failure; diastolic dysfunction; persistent diastolic dysfunction; prognostic implications; subclinical dysfunction; systolic dysfunction; therapeutic implications

Year:  2018        PMID: 29892470      PMCID: PMC5971666          DOI: 10.15420/cfr.2018:24:2

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN: 2057-7540


  56 in total

1.  Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists.

Authors:  Jacob Abraham; James O Mudd; Navin K Kapur; Navin Kapur; Kelly Klein; Hunter C Champion; Ilan S Wittstein
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

2.  Diastolic function improves after resolution of takotsubo cardiomyopathy.

Authors:  Sanjay Kumar; Micael Waldenborg; Priya Bhumireddy; Keshwar Ramkissoon; Karin Loiske; Antony L Innasimuthu; Richard S Grodman; John F Heitner; Kent Emilsson; Jason M Lazar
Journal:  Clin Physiol Funct Imaging       Date:  2014-09-10       Impact factor: 2.273

3.  Increased ventricular wall stress and late gadolinium enhancement in Takotsubo cardiomyopathy.

Authors:  Peter Alter; Jens H Figiel; Marga B Rominger
Journal:  Int J Cardiol       Date:  2014-01-05       Impact factor: 4.164

4.  Brain-Heart Disconnection: A Protective Effect of Diabetes Mellitus in Takotsubo Cardiomyopathy.

Authors:  Lovely Chhabra
Journal:  Am J Cardiol       Date:  2016-02-15       Impact factor: 2.778

Review 5.  Diastolic dysfunction.

Authors:  Euy-Myoung Jeong; Samuel C Dudley
Journal:  Circ J       Date:  2015-02-05       Impact factor: 2.993

6.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

7.  Low prevalence of diabetes mellitus in patients with Takotsubo syndrome: A plausible 'protective' effect with pathophysiologic connotations.

Authors:  John E Madias
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2015-02-11

Review 8.  Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction.

Authors:  Abhiram Prasad; Amir Lerman; Charanjit S Rihal
Journal:  Am Heart J       Date:  2008-01-31       Impact factor: 4.749

Review 9.  Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning.

Authors:  Alexander R Lyon; Paul S C Rees; Sanjay Prasad; Philip A Poole-Wilson; Sian E Harding
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-01

Review 10.  Late-onset dynamic outflow tract gradient in the setting of tako-tsubo cardiomyopathy: An interesting phenomenon with potential implications?

Authors:  Kenan Yalta; Ertan Yetkin
Journal:  Indian Heart J       Date:  2017-01-02
View more
  7 in total

1.  Concomitant cardiac and cerebral takotsubo syndrome requires specific management.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Auton Res       Date:  2018-09-17       Impact factor: 4.435

Review 2.  Cardiac Biomarkers in the Setting of Asthma Exacerbations: a Review of Clinical Implications and Practical Considerations.

Authors:  Kenan Yalta; Tulin Yalta; Muhammet Gurdogan; Orkide Palabıyık; Ertan Yetkın
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-28       Impact factor: 4.806

3.  Takotsubo cardiomyopathy complicated by cardiac tamponade due to non-hemorrhagic pericardial effusion: a case report.

Authors:  Yuta Nagamori; Takuto Hamaoka; Hisayoshi Murai; Shinichiro Takashima; Takeshi Kato; Soichiro Usui; Kenji Sakata; Hiroshi Furusho; Masaaki Kawashiri; Masayuki Takamura
Journal:  BMC Cardiovasc Disord       Date:  2020-02-06       Impact factor: 2.298

4.  Case Report: Takotsubo Cardiomyopathy in Bickerstaff Brainstem Encephalitis Triggered by COVID-19.

Authors:  Mizuki Kimura; Shunta Hashiguchi; Kenichi Tanaka; Manato Hagiwara; Keita Takahashi; Yosuke Miyaji; Hideto Joki; Hiroshi Doi; Michiaki Koga; Hideyuki Takeuchi; Fumiaki Tanaka
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

5.  Pheochromocytoma and Takotsubo Syndrome: An Ominous Duo.

Authors:  Kenan Yalta; Tülin Yalta; Ertan Yetkin
Journal:  Anatol J Cardiol       Date:  2022-08       Impact factor: 1.475

Review 6.  Takotsubo Cardiomyopathy-Acute Cardiac Dysfunction Associated With Neurological and Psychiatric Disorders.

Authors:  Sylvia J Buchmann; Dana Lehmann; Christin E Stevens
Journal:  Front Neurol       Date:  2019-08-22       Impact factor: 4.003

7.  Recurrent Takotsubo Cardiomyopathy: A Puzzle Yet to be Solved

Authors:  Kenan Yalta; Caglar Kaya
Journal:  Arq Bras Cardiol       Date:  2020-09       Impact factor: 2.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.